FDA Considers Expanding Femara

Breast cancer drug, Femara, was submitted for additional regulatory approval by the US Food and Drug Administration today from Swiss pharmaceutical company Novartis. Femara presents the hope of post-surgery medication that helps older women fight tumors.

Sprint To Get Unwired

The boards of directors of Sprint and US Unwired have approved an agreement in which Sprint will acquire US Unwired for about $1.3 billion.